hexamethonium and Peripheral Arterial Disease
hexamethonium has been researched along with Peripheral Arterial Disease in 1 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Peripheral Arterial Disease: Lack of perfusion in the EXTREMITIES resulting from atherosclerosis. It is characterized by INTERMITTENT CLAUDICATION, and an ANKLE BRACHIAL INDEX of 0.9 or less.
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
TRENCH, NF | 1 |
MONFORT, J | 1 |
Other Studies
1 other study available for hexamethonium and Peripheral Arterial Disease
Article | Year |
---|---|
[Use of hexamethonium as test for indication for sympathectomy in peripheral arteriopathy of the lower extremities].
Topics: Hexamethonium; Lower Extremity; Muscle Relaxants, Central; Peripheral Arterial Disease; Peripheral V | 1953 |